Genomenon is an AI-driven genetic intelligence company that transforms biomedical information into actionable insights for precision medicine. The company uses large-scale AI combined with expert human curation to convert scientific literature into a literature-derived, real-world evidence (RWE) engine that helps clinicians make better diagnostic and therapeutic decisions for rare diseases and cancer. Genomenon's platforms and services are used by more than 250 clinical laboratories and pharma organizations worldwide for diagnostic interpretation, variant curation, and evidence-based decision-making across the drug development lifecycle. Each year, the company's technology helps inform care for tens of thousands of patients facing rare, complex, and time-sensitive conditions by reducing uncertainty and delivering clinical answers.
Beta · Sourced from candidate reports
Be the first to share your experience with Genomenon.
Your reply helps other candidates know what to expect.
